GREGORIO
CASTELLANO TORTAJADA
Researcher to 2020
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublications in collaboration with researchers from Hospital Clínico San Carlos de Madrid (1)
2017
-
Therapy with ombitasvir/paritaprevir/ritonavir plus dasabuvir is effective and safe for the treatment of genotypes 1 and 4 hepatitis C virus (HCV) infection in patients with severe renal impairment: A multicentre experience
Journal of Viral Hepatitis, Vol. 24, Núm. 6, pp. 464-471